Literature DB >> 10453398

Basic kinetics of 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in canine myocardium.

R Nohara1, R Hosokawa, T Hirai, K Okuda, M Ogino, Y Fujibayashi, M Fujita, S Sasayama.   

Abstract

BMIPP is a radioiodinated fatty acid analogue used for myocardial single photon emission CT (SPECT) imaging based on high cardiac fatty acid metabolism. In normal dogs, 74% of the injected BMIPP was instantly extracted and was then retained in 65.3%. The washout of the retained radioactivity was low, and most of the washout was alpha- and beta-oxidation metabolites. ATP concentration plays an important role in the myocardial uptake and retention of BMIPP. The ATP-dependent BMIPP uptake at the TG pool was strongly regulated by etomoxir with modifying mitochondrial beta-oxidation and subsequent ATP production. Thus, myocardial viability was reflected on the BMIPP uptake in acute ischemia. In spite of insignificant changes in early extraction and retention. BMIPP back diffusion (r = -0.92) and full-oxidation metabolite (r = 0.78) were correlated with the severity of ischemia. Mismatched region of BMIPP with flow (Tl-201) showed decreased metabolic enzymes such as citrate synthase and 3-hydroxyacyl-CoA dehydrogenase. These data suggest that BMIPP would be feasible for detecting cellular energy state from lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10453398     DOI: 10.1023/a:1006167713330

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  25 in total

1.  Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration.

Authors:  Y Fujibayashi; Y Yonekura; Y Takemura; K Wada; K Matsumoto; N Tamaki; K Yamamoto; J Konishi; A Yokoyama
Journal:  J Nucl Med       Date:  1990-11       Impact factor: 10.057

2.  Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: implications for clinical SPECT.

Authors:  R Hosokawa; R Nohara; Y Fujibayashi; K Okuda; M Ogino; T Hata; M Fujita; N Tamaki; J Konishi; S Sasayama
Journal:  J Nucl Med       Date:  1997-12       Impact factor: 10.057

3.  Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting.

Authors:  N Tamaki; Y Yonekura; K Yamashita; H Saji; Y Magata; M Senda; Y Konishi; K Hirata; T Ban; J Konishi
Journal:  Am J Cardiol       Date:  1989-10-15       Impact factor: 2.778

4.  Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction.

Authors:  M Tateno; N Tamaki; M Yukihiro; T Kudoh; N Hattori; E Tadamura; R Nohara; T Suzuki; K Endo; J Konishi
Journal:  J Nucl Med       Date:  1996-12       Impact factor: 10.057

5.  Metabolic fate of iodine-123-BMIPP in canine myocardium after administration of etomoxir.

Authors:  R Hosokawa; R Nohara; Y Fujibayashi; K Okuda; M Ogino; T Hata; M Fujita; N Tamaki; J Konishi; S Sasayama
Journal:  J Nucl Med       Date:  1996-11       Impact factor: 10.057

6.  Retention and clearance of C-11 palmitic acid in ischemic and reperfused canine myocardium.

Authors:  M Schwaiger; H R Schelbert; R Keen; J Vinten-Johansen; H Hansen; C Selin; J Barrio; S C Huang; M E Phelps
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

7.  Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted alpha- and beta-methyl-branched fatty acids.

Authors:  M M Goodman; G Kirsch; F F Knapp
Journal:  J Med Chem       Date:  1984-03       Impact factor: 7.446

8.  Structurally modified fatty acids: clinical potential as tracers of metabolism.

Authors:  R Dudczak; R Schmoliner; P Angelberger; F F Knapp; M M Goodman
Journal:  Eur J Nucl Med       Date:  1986

9.  Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography.

Authors:  N Tamaki; M Kawamoto; E Tadamura; Y Magata; Y Yonekura; R Nohara; S Sasayama; K Nishimura; T Ban; J Konishi
Journal:  Circulation       Date:  1995-03-15       Impact factor: 29.690

10.  Effect of metabolic substrate on BMIPP metabolism in canine myocardium.

Authors:  R Nohara; R Hosokawa; T Hirai; K Okuda; M Ogino; Y Fujibayashi; M Fujita; S Sasayama
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

View more
  2 in total

1.  Reduced 123I-BMIPP uptake implies decreased myocardial flow reserve in patients with chronic stable angina.

Authors:  Hiroyuki Kageyama; Koichi Morita; Chietsugu Katoh; Takahiro Tsukamoto; Kazuyuki Noriyasu; Megumi Mabuchi; Masanao Naya; Yuko Kawai; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07-23       Impact factor: 9.236

2.  Relevance of I-BMIPP delayed scintigraphic imaging for patients with angina pectoris - a pilot study.

Authors:  Kohei Koyama; Yoshihiro J Akashi; Keisuke Kida; Kengo Suzuki; Yuki Ishibashi; Haruki Musha; Maciej Banach
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.